Agenda

Join us March 15-17, 2024 for informative educational sessions and networking with colleagues.

The 2024 RMIBD Conference Agenda* is as follows:

Friday, March 15, 2024

6:00-7:30 pm Registration & Welcome Reception

Saturday, March 16, 2024

6:00-6:55 am Registration & Breakfast with Faculty in Exhibit Hall

6:55-7:00 am Opening Remarks

Course Directors: Mark Gerich, MD and John Valentine, MD

7:00-7:30 am New and Emerging Treatments for IBD

Michael Chiorean, MD; Swedish Medical Center, Seattle, WA

7:30-8:00 am Biosimilars 2024

Jessica Johnson, MD; University of Utah

8:00-8:30 am Dietary Therapy for IBD

Debbie Cheng, MD; University of Colorado Anschutz Medical Campus

8:30-9:00 am Optimizing Current IBD Therapies

Millie Long, MD; University of North Carolina

9:00-9:30 am Pouch Dysfunction and Complications

Amir Kashani, MD; University of Utah

9:30-10:00 am Panel Discussion

10:00 am-4:00 pm Break

3:30 - 4:00 pm Networking Break and Snacks

4:00-4:30 pm Perianal Crohn's Disease

Waseem Ahmed, MD; University of Colorado Anschutz Medical Campus

4:30-5:00 pm Preventing Complications of IBD

Millie Long MD; University of North Carolina

5:00-5:30 pm Stricture Management

Calen Steiner, MD; University of Colorado Anschutz Medical Campus

5:30-6:00 pm Management of Intra-abdominal Complications

Ben Click, MD; University of Colorado Anschutz Medical Campus

6:00-6:15 pm Panel Discussion

6:15-6:45 pm Case Presentation & Audience Discussion

Blair Fennimore, MD and Trey Simril, MD

University of Colorado Anschutz Medical Campus

6:45 pm ADJOURN

Sunday, March 17, 2024

6:00-6:55 am Breakfast with Faculty in Exhibit Hall

6:55-7:00 am Opening Remarks

7:00-7:30 am Mental Health and IBD

Ann Flynn, MD; University of Utah

7:30-8:00 am Intestinal Ultrasound for IBD

Michael Chiorean, MD; Swedish Medical Center, Seattle, WA

8:00-8:30 am AI in IBD

Frank Scott, MD; University of Colorado Anschutz Medical Campus

8:30-9:00 am IBD Year in Review

John Valentine, MD; University of Utah

9:00-9:15 am Panel Discussion

9:15-9:45 am Case Presentation & Audience Discussion

Blair Fennimore, MD and Taylor Karl, MD

University of Colorado Anschutz Medical Campus

9:45-10:00 am Closing Remarks

10:00 am Adjourn

*Subject to change

Learning objectiveS

1) Identify the latest diagnostic and therapeutic approaches in IBD.

2) Develop an approach to treating patients with penetrating Crohn’s disease and complications of J-pouch.

3) Recount the impact of diet and mental health on clinical outcomes for IBD patients.

4) Relate the role of therapeutic drug monitoring and other methods to optimize therapy prior to changing therapy in

patients that are not doing well.

5) Recognize the impact that Artificial Intelligence will have on Inflammatory Bowel Disease practice.

ACCREDITATION STATEMENT

The University of Colorado School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To earn board credit, the attendee must participate in the CME activity including the evaluation component. By participating in this event and requesting board credit, I understand that my learner completion data will be shared with the ACCME and the applicable certifying board.